课题基金 / 基金详情

Elucidation of anti-obese mechanism via the retinoic acid receptor signal controlled by SMRT

Elucidation of anti-obese mechanism via the retinoic acid receptor signal controlled by SMRT
通过 SMRT 控制的视黄酸受体信号阐明抗肥胖机制
批准号:
18K08486
负责人:
Shimizu Hiroaki
金额:
$2.83万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2018
资助国家:
日本
项目状态:
已结题
起止时间:
2018-04-01 至 2022-03-31

项目摘要

项目成果

Shimizu Hiroaki的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Nuclear corepressor SMRT is a strong regulator of body weight independently of its ability to regulate thyroid hormone action
核辅阻遏物 SMRT 是一种强大的体重调节剂,独立于其调节甲状腺激素作用的能力
DOI: 10.1371/journal.pone.0220717
发表时间: 2019
期刊: PLOS ONE
影响因子: 3.7
作者: [Hiroaki Shimizu, Yu Lu, Kristen R. Vella, Federico Damilano, Inna Astapova, Izuki Amano, Megan Ritter, Molly R. Gallop, Anthony N. Rosenzweig, Ronald N. Cohen, Anthony N. Hollenberg]
通讯作者: Anthony N. Hollenberg
DOI: --
发表时间: 2020
期刊:
影响因子: --
作者: [Hiroaki Shimizu, Yasuhiro Horibata, Chieko Aoyama, Izuki Amano, Megan Ritter, Hiromi Ando, Hiroyuki Sugimoto, Anthony Neil Hollenberg]
通讯作者: Anthony Neil Hollenberg
Biological role of metadherin in liver metastases of colon cancer and development of novel molecular target therapy
  • 批准号:
    19K09134
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.75万
  • 财政年份:
    2019
  • 负责人:
    Shimizu Hiroaki
  • 依托单位:
Development of a new experimental model of chronic cerebral ischemia with vascular endothelial impairment and elucidation of hyperperfusion following vascular reconstruction
  • 批准号:
    18K08934
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2018
  • 负责人:
    Shimizu Hiroaki
  • 依托单位:
Multidisciplinary Approach for Arteriovenous Malformation Based on Computational Fluid Dynamics
  • 批准号:
    26282141
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.65万
  • 财政年份:
    2014
  • 负责人:
    Shimizu Hiroaki
  • 依托单位: